1. Home
  2. FDMT

as 09-03-2025 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Founded: 2013 Country:
United States
United States
Employees: N/A City: EMERYVILLE
Market Cap: 192.2M IPO Year: 2020
Target Price: $30.63 AVG Volume (30 days): 727.2K
Analyst Decision: Buy Number of Analysts: 9
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.52 EPS Growth: N/A
52 Week Low/High: $2.23 - $17.41 Next Earning Date: 08-11-2025
Revenue: $33,000 Revenue Growth: -99.84%
Revenue Growth (this year): 9921.62% Revenue Growth (next year): -13.54%

FDMT Daily Stock ML Predictions

Share on Social Networks: